NasdaqGS - Nasdaq Real Time Price USD

Myriad Genetics, Inc. (MYGN)

Time to buy MYGN?
4.0300
-0.2400
(-5.62%)
At close: May 8 at 4:00:00 PM EDT
4.1000
+0.07
+(1.74%)
After hours: May 8 at 7:53:12 PM EDT
Time to buy MYGN?
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
837,600
837,600
753,200
678,400
690,600
Cost of Revenue
252,200
252,200
236,200
202,000
197,600
Gross Profit
585,400
585,400
517,000
476,400
493,000
Operating Expense
673,400
673,400
661,600
600,100
619,700
Operating Income
-88,000
-88,000
-144,600
-123,700
-126,700
Net Non Operating Interest Income Expense
-1,100
-1,100
-400
-600
-5,900
Other Income Expense
-34,400
-34,400
-117,200
-16,300
75,500
Pretax Income
-123,500
-123,500
-262,200
-140,600
-57,100
Tax Provision
3,800
3,800
1,100
-28,600
-29,900
Net Income Common Stockholders
-127,300
-127,300
-263,300
-112,000
-27,200
Diluted NI Available to Com Stockholders
-127,300
-127,300
-263,300
-112,000
-27,200
Basic EPS
-1.28
-1.41
-3.18
-1.39
-0.35
Diluted EPS
-1.28
-1.41
-3.18
-1.39
-0.35
Basic Average Shares
89,475
90,600
82,800
80,600
78,000
Diluted Average Shares
89,475
90,600
82,800
80,600
78,000
Total Operating Income as Reported
-123,500
-123,500
-257,400
-140,600
-190,500
Total Expenses
925,600
925,600
897,800
802,100
817,300
Net Income from Continuing & Discontinued Operation
-127,300
-127,300
-263,300
-112,000
-27,200
Normalized Income
-99,255
-99,255
-174,188
-98,530.7000
19,374
Interest Income
1,700
1,700
2,500
2,600
700
Interest Expense
2,800
2,800
2,900
3,200
6,600
Net Interest Income
-1,100
-1,100
-400
-600
-5,900
EBIT
-120,700
-120,700
-259,300
-137,400
-50,500
EBITDA
-59,500
-59,500
-197,400
-84,700
12,300
Reconciled Cost of Revenue
252,200
252,200
236,200
202,000
197,600
Reconciled Depreciation
61,200
61,200
61,900
52,700
62,800
Net Income from Continuing Operation Net Minority Interest
-127,300
-127,300
-263,300
-112,000
-27,200
Total Unusual Items Excluding Goodwill
-35,500
-35,500
-112,800
-16,900
-63,800
Total Unusual Items
-35,500
-35,500
-112,800
-16,900
-63,800
Normalized EBITDA
-24,000
-24,000
-84,600
-67,800
76,100
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
-7,455
-7,455
-23,688
-3,430.7000
-17,226
12/31/2021 - 10/6/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PSNL Personalis, Inc.
5.16
+6.61%
 
GH Guardant Health, Inc.
41.68
+4.88%
 
NEO NeoGenomics, Inc.
8.13
+1.63%
 
CSTL Castle Biosciences, Inc.
17.21
+0.94%
 
WGS GeneDx Holdings Corp.
56.36
-1.71%
 
VCYT Veracyte, Inc.
31.21
+1.20%
 
WAT Waters Corporation
350.88
+1.57%
 
NTRA Natera, Inc.
162.57
+1.54%
 
QGEN Qiagen N.V.
42.16
-1.10%
 
EXAS Exact Sciences Corporation
53.06
-0.41%